CLINICAL ROLE -
Trends in Medication Utilization and the Cost of Treatment for Gout
With new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.
Read More
Beth A. Malow, MD, MS, FAAN: ‘As Health Care Professionals, Climate Change Is In Our Lane’
AAN 2025: Paving the Way for Precision Medicine in Alzheimer, Neurodegenerative Diseases
Study Reveals Low RSV Knowledge and Vaccine Uptake Among Hospitalized Older Adults
MANIFEST-2 Study: Pelabresib Plus Ruxolitinib Is Superior to JAK Inhibitors Alone